Clearance Summary
ImmuLisa Enhanced Gliadin IgA Antibody ELISA, ImmuLisa Enhanced Gliadin IgG Antibody ELISA received FDA 510(k) clearance under submission number K163177, sponsored by Immco Diagnostics, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Immunology review panel. The statutory decision date of record is 2017-07-28.
- Submission: K163177
- Applicant / Sponsor: Immco Diagnostics, Inc.
- Clearance pathway: Traditional
- Review panel: Immunology
- Device class: Class II
- Regulation citation: 21 CFR 866.5750
- Decision date: 2017-07-28
Classification & Regulation
This clearance is catalogued under FDA product code MST and 21 CFR 866.5750, within the Immunology review panel as a Class II device.